Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of hypertension with propranolol and hydralazine.

× No keyword cloud information.

11 in total

Review 1. The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors: B N Prichard
Journal: Br J Clin Pharmacol Date: 1978-05 Impact factor: 4.335

Review 2. Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors: G L Wollam; R W Gifford; R C Tarazi
Journal: Drugs Date: 1977-12 Impact factor: 9.546

3. Cadralazine versus prazosin as second-step treatment in hypertensive patients on beta-blockers: a randomized multicentre study. The Italian Multicentre Study Group.

Authors: S Caponnetto; E Valvo; P Mocarelli; D Alberti; S Savonitto
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

Review 4. Beta-adrenergic receptor blocking drugs in hypertension.

Authors: F O Simpson
Journal: Drugs Date: 1974 Impact factor: 9.546

5. Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.

Authors: M M El-Mehairy; A Shaker; M Ramadan; S Hamza; S S Tadros
Journal: Br J Clin Pharmacol Date: 1979 Impact factor: 4.335

6. Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.

Authors: E van der Veur; B S ten Berge; A J Donker; J F May; H Wesseling
Journal: Eur J Clin Pharmacol Date: 1982 Impact factor: 2.953

7. Treatment of hypertension successively with a diuretic, clonidine or a beta-blocking agent and hydralazine.

Authors: T Pitkäjärvi; P Ala-Laurila; R Ruosteenoja; P Torsti; S E Masar
Journal: Eur J Clin Pharmacol Date: 1977-11-14 Impact factor: 2.953

8. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.

Authors: I Persson
Journal: Eur J Clin Pharmacol Date: 1975-12-19 Impact factor: 2.953

9. Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors: M Motolese; G Muiesan; A Colombi
Journal: Eur J Clin Pharmacol Date: 1975 Impact factor: 2.953

10. Hydralazine, antinuclear antibodies, and the lupus syndrome.

Authors: R Mansilla-Tinoco; S J Harland; P J Ryan; R M Bernstein; C T Dollery; G R Hughes; C J Bulpitt; A Morgan; J M Jones
Journal: Br Med J (Clin Res Ed) Date: 1982-03-27